AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline
benzinga.com/news/earnings/25/01/43392796/abbvie-jumps-after-q4-earnings-beat-skyrizi-and-rinvoq-boom-offsets-humira-decline
AbbVie Inc. (NYSE:ABBV) shares are trading higher on Friday. The company reported fourth-quarter adjusted earnings per share of $2.16, beating the street view of $2.11.
Quarterly sales of $15.102 billion, outpacing the analyst consensus estimate of $14.827 billion. Revenues soared 5.6%…
This story appeared on benzinga.com, 2025-01-31 15:00:59.